Impact of Infant Feeding on Newborn Metabolomic Profile
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this study is the evaluation with untargeted modalities, of the urine metabolomic profile in a group of infants fed with a standard formula, a group of infants fed with a formula supplemented with functional ingredients and a group of breast-fed infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2012
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2012
CompletedFirst Submitted
Initial submission to the registry
May 24, 2012
CompletedFirst Posted
Study publicly available on registry
May 28, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedFebruary 4, 2015
February 1, 2015
1.3 years
May 24, 2012
February 2, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Metabolite patterns associated with different dietary regimens
Urine will be analysed using 1H-NMR. Data will be analyzed through the use of software products to enable the discovery of hundreds of different metabolites involved in multiple pathways and connected with different conditions. The metabolites on which the univariate analysis will be performed are the most important revealed by the multivariate analysis (VIP variables) and Student's statistical test will be performed.
At enrolment, after 60 and 135 days of life
Study Arms (3)
GROUP 1
EXPERIMENTALInfant formula supplemented with with functional ingredients (galacto-oligosaccharides, beta-palmitate, fermented milk). Infant formula with functional ingredients is in compliance with Directive 2006/141/CE on infant formulae and follow-on formulae.
GROUP 2
OTHERStandard infant formula, in compliance with Directive 2006/141/CE on infant formulae and follow-on formulae, without functional ingredients.
CONTROL GROUP
OTHERBreast milk
Interventions
Infant formula supplemented with functional ingredients (galacto-oligosaccharides, beta-palmitate, acidified milk. Infant formula with functional ingredients is in compliance with Directive 2006/141/CE on infant formulae and follow-on formulae.
Standard infant formula, in compliance with Directive 2006/141/CE on infant formulae and follow-on formulae, without functional ingredients.
Eligibility Criteria
You may qualify if:
- Infants being exclusively either breastfed or formula-fed by the 21st day of life
- Infants of both sexes born with natural or caesarian delivery
- Gestational age between 37 and 42 completed weeks
- Birth weight between 10th and 90th percentile of birth weight for gestational age, according to the North-Italian growth charts
- Single birth
- Caucasian parents
You may not qualify if:
- Infants with genetic and/or congenital diseases
- Infants receiving antibiotic therapy
- Infants with neonatal diseases requiring hospitalisation for longer than 7 days
- Infants at risk for atopy and/or having familial history for atopy
- Mothers with metabolic or chronic diseases
- Infant selected for another clinical study
- Parents refusing to sign a written informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Heinz Italia SpAlead
- Fondazione IRCCS Policlinico San Matteo di Paviacollaborator
- University of Cagliaricollaborator
Study Sites (1)
Fondazione Irccs Policlinico "San Matteo" - Struttura Complessa Di Neonatologia, Patologia Neonatale E Terapia Intensiva
Pavia, PV, 27100, Italy
Related Publications (19)
Goodacre R, Vaidyanathan S, Dunn WB, Harrigan GG, Kell DB. Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol. 2004 May;22(5):245-52. doi: 10.1016/j.tibtech.2004.03.007. No abstract available.
PMID: 15109811BACKGROUNDRyan D, Robards K. Metabolomics: The greatest omics of them all? Anal Chem. 2006 Dec 1;78(23):7954-8. doi: 10.1021/ac0614341. No abstract available.
PMID: 17134127BACKGROUNDFanos V, Barberini L, Antonucci R, Atzori L. Metabolomics in neonatology and pediatrics. Clin Biochem. 2011 May;44(7):452-454. doi: 10.1016/j.clinbiochem.2011.03.006. No abstract available.
PMID: 22036322BACKGROUNDAtzori L, Antonucci R, Barberini L, Griffin JL, Fanos V. Metabolomics: a new tool for the neonatologist. J Matern Fetal Neonatal Med. 2009;22 Suppl 3:50-3. doi: 10.1080/14767050903181500.
PMID: 19701858BACKGROUNDGoodacre R. Metabolomics of a superorganism. J Nutr. 2007 Jan;137(1 Suppl):259S-266S. doi: 10.1093/jn/137.1.259S.
PMID: 17182837BACKGROUNDNicholson JK, Wilson ID. Opinion: understanding 'global' systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov. 2003 Aug;2(8):668-76. doi: 10.1038/nrd1157. No abstract available.
PMID: 12904817BACKGROUNDNicholson JK, Holmes E, Lindon JC, Wilson ID. The challenges of modeling mammalian biocomplexity. Nat Biotechnol. 2004 Oct;22(10):1268-74. doi: 10.1038/nbt1015.
PMID: 15470467BACKGROUNDCarraro S, Giordano G, Reniero F, Perilongo G, Baraldi E. Metabolomics: a new frontier for research in pediatrics. J Pediatr. 2009 May;154(5):638-44. doi: 10.1016/j.jpeds.2009.01.014. No abstract available.
PMID: 19364557BACKGROUNDJaneckova H, Hron K, Wojtowicz P, Hlidkova E, Baresova A, Friedecky D, Zidkova L, Hornik P, Behulova D, Prochazkova D, Vinohradska H, Peskova K, Bruheim P, Smolka V, Stastna S, Adam T. Targeted metabolomic analysis of plasma samples for the diagnosis of inherited metabolic disorders. J Chromatogr A. 2012 Feb 24;1226:11-7. doi: 10.1016/j.chroma.2011.09.074. Epub 2011 Oct 4.
PMID: 22018716BACKGROUNDAtzori L, Antonucci R, Barberini L, Locci E, Cesare Marincola F, Scano P, Cortesi P, Agostiniani R, Weljie A, Lai A, Fanos V. 1H NMR-based metabolic profiling of urine from children with nephrouropathies. Front Biosci (Elite Ed). 2010 Jan 1;2(2):725-32. doi: 10.2741/e132.
PMID: 20036916BACKGROUNDAtzori L, Antonucci R, Barberini L, Locci E, Marincola FC, Scano P, Cortesi P, Agostiniani R, Defraia R, Weljie A, Gazzolo D, Lai A, Fanos V. 1H NMR-based metabolomic analysis of urine from preterm and term neonates. Front Biosci (Elite Ed). 2011 Jun 1;3(3):1005-12. doi: 10.2741/e306.
PMID: 21622109BACKGROUNDCiccarelli S, Atzori L, Noto A, Barberini L, Fanos V, Caramia G, Agostino R. Spontaneous vs cesarean delivery: a metabolomic point of view. J Matern Fetal Neonatal Med 24(S(2):1-2, 2011.
BACKGROUNDScalbert A, Brennan L, Fiehn O, Hankemeier T, Kristal BS, van Ommen B, Pujos-Guillot E, Verheij E, Wishart D, Wopereis S. Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research. Metabolomics. 2009 Dec;5(4):435-458. doi: 10.1007/s11306-009-0168-0. Epub 2009 Jun 12.
PMID: 20046865BACKGROUNDGibney MJ, Walsh M, Brennan L, Roche HM, German B, van Ommen B. Metabolomics in human nutrition: opportunities and challenges. Am J Clin Nutr. 2005 Sep;82(3):497-503. doi: 10.1093/ajcn.82.3.497.
PMID: 16155259BACKGROUNDWalsh MC, Brennan L, Malthouse JP, Roche HM, Gibney MJ. Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. Am J Clin Nutr. 2006 Sep;84(3):531-9. doi: 10.1093/ajcn/84.3.531.
PMID: 16960166BACKGROUNDPhipps AN, Stewart J, Wright B, Wilson ID. Effect of diet on the urinary excretion of hippuric acid and other dietary-derived aromatics in rat. A complex interaction between diet, gut microflora and substrate specificity. Xenobiotica. 1998 May;28(5):527-37. doi: 10.1080/004982598239443.
PMID: 9622854BACKGROUNDBell JD, Sadler PJ, Morris VC, Levander OA. Effect of aging and diet on proton NMR spectra of rat urine. Magn Reson Med. 1991 Feb;17(2):414-22. doi: 10.1002/mrm.1910170213.
PMID: 1829498BACKGROUNDZhang X, Yap Y, Wei D, Chen G, Chen F. Novel omics technologies in nutrition research. Biotechnol Adv. 2008 Mar-Apr;26(2):169-76. doi: 10.1016/j.biotechadv.2007.11.002. Epub 2007 Nov 19.
PMID: 18164161BACKGROUNDBertram HC, Hoppe C, Petersen BO, Duus JO, Molgaard C, Michaelsen KF. An NMR-based metabonomic investigation on effects of milk and meat protein diets given to 8-year-old boys. Br J Nutr. 2007 Apr;97(4):758-63. doi: 10.1017/S0007114507450322.
PMID: 17349089BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mauro Stronati, Prof.
FONDAZIONE IRCCS POLICLINICO "SAN MATTEO" - STRUTTURA COMPLESSA DI NEONATOLOGIA, PATOLOGIA NEONATALE E TERAPIA INTENSIVA
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 24, 2012
First Posted
May 28, 2012
Study Start
April 1, 2012
Primary Completion
August 1, 2013
Study Completion
December 1, 2014
Last Updated
February 4, 2015
Record last verified: 2015-02